chartexchange

NRSN
NeuroSense Therapeutics Ltd.
stockNASDAQ

At CloseNov 17, 2026 10:58:56 AM EST
1.50USD-4.473%(-0.07)11,883
After-hoursNov 17, 2026 4:00:30 PM EST
1.51USD+1.003%(+0.01)
1.1800Bid2.0300Ask0.8500Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Herzliya, Israel
Previous Close
$1.57
Beta
1.50
52-Week High
$25.40 2025-11-19
52-Week Low
$1.10 2026-11-02
SMA 50
$3.97
SMA 200
$11.91
Avg. Vol 10D
31,492
Avg. Vol 30D
39,004
Avg. Vol 90D
27,633
Relative Vol
0.27
1.19M
12.9700%
639
Sep 14, 2026 · 1-for-20 (reverse)
NRSN Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Performance
PeriodPriceDateChangeBeta
1W1.982026-11-10-22.73%-0.908
1M3.072026-10-16-50.16%1.820
3M8.642026-08-17-82.29%2.962
6M15.412026-05-18-90.07%2.303
1Y20.762025-11-17-92.63%1.498
2Y23.602024-11-18-93.52%—
5Y80.802021-12-09-98.11%0.713
NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $1.53, and today's volume is 10,533. NRSN is down 2.236% today. The 30 day average volume is 39,004. NRSN market cap is $2.90M with 1.90M shares outstanding.